BOSTON -- Massachusetts shut down another compounding pharmacy over sterility concerns after a surprise inspection prompted by the nationwide meningitis outbreak linked to a different company, state officials said.
Dr. Madeleine Biondolillo of the state Department of Public Health said inspectors went to the Waltham location of Rhode Island-based Infusion Resource last week and found significant issues with the environment in which drugs were being mixed.
The company was inspected when it first opened in December 2009 and there had been no complaints since. She said the manager of record at the company was a former employee at Ameridose, which is owned by the same people who ran New England Compounding Center, the company linked to the meningitis outbreak.
She would not identify the drugs or say what specific issues investigators found at Infusion Resource, but she said they were concerned about sterility. The company mixes sterile injectable drugs for people who have been released from hospitals.
The company agreed to contact its 40 patients and their doctors and ask them to return any unused medication.
Biondolillo says there is no indication any medication the company compounded is unsafe. She said the company also had an area to administer intravenous drugs, which it was not licensed to do. She says the company voluntarily surrendered its pharmacy license this weekend.
Company chief executive Bernard F. Lambrese said the company will immediately fix issues identified by investigators, including a crack in a window, flooring in a clean room and a leak in a refrigerator drain hose. -- AP